
Low C-peptide reflects reduced endogenous insulin production — classically type 1 diabetes and LADA (autoimmune beta-cell destruction), and late-stage type 2 diabetes with beta-cell exhaustion.
Other causes: exogenous insulin therapy suppressing pancreatic secretion, pancreatectomy or pancreatic damage, and prolonged fasting or low food intake.
High C-peptide reflects excess endogenous insulin production — most often the compensatory hyperinsulinemia of insulin resistance seen in obesity, metabolic syndrome, and early type 2 diabetes.
Other causes: insulinoma (insulin-secreting tumor), Cushing's syndrome, insulin-stimulating drugs such as sulfonylureas, and reduced renal clearance in kidney insufficiency.
Provides a comprehensive metabolic assessment of blood glucose control using a static multi-biomarker approach.
View Full Analysis100% free and private. Enter only the values you have.
Access interactive features, detailed explanations, and AI interpretations.
About the site author
My personal mission is to extend human lifespan by collectively adding 1 million years to people's lives.
That’s why I made this site 100% free, no sign-up, no email. Just instant results.
Zsolt SzaboPrecision Health Consultant for Longevity Clinics